Skip to main content
. 2016 Dec 2;8(2):2083–2095. doi: 10.18632/oncotarget.13781

Figure 2. PI3K pathway inhibitors in clinical development.

Figure 2

Examples of inhibitors in clinical development which target various nodes of the PI3K signalling pathway, including class I PI3K (pan or isoform), AKT and mTOR. Specific targets are given in brackets.